Taro Pharmaceutical Industries Ltd (NYSE:TARO)

81.56
Delayed Data
As of Aug 16
 +1.04 / +1.29%
Today’s Change
76.93
Today|||52-Week Range
109.42
-3.64%
Year-to-Date
No recent news for Taro Pharmaceutical Industries Ltd.

Today’s Trading

Previous close80.52
Today’s open80.97
Day’s range80.65 - 82.05
Volume30,164
Average volume (3 months)64,871
Market cap$3.1B
Data as of 6:30pm ET, 08/16/2019

Growth & Valuation

Earnings growth (last year)+37.39%
Earnings growth (this year)+1.38%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+1.21%
P/E ratio11.3
Price/Sales6.29
Price/Book1.62

Competitors

 Today’s
change
Today’s
% change
RAREUltragenyx Pharmaceu...+1.78+3.13%
ALKSAlkermes Plc+0.80+3.84%
GBTGlobal Blood Therape...+1.34+2.87%
ARNAArena Pharmaceutical...+2.84+5.37%
Data as of 4:00pm ET, 08/16/2019

Financials

Next reporting dateNovember 5, 2019
EPS forecast (this quarter)$2.15
Annual revenue (last year)$669.9M
Annual profit (last year)$281.8M
Net profit margin42.06%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Uday Vijaykumar Baldota
Vice President &
Head-Operations
Itamar Karsenti
Corporate headquarters
Haifa Bay, Haifa

Forecasts